DocWire News

TikTok skin care for kids may be harming—not helping. Findings: 🚫 Only 26% used SPF ⚠️ 11+ irritating actives/video 🤳 Often push “lighter, brighter” skin ideals Is this beauty or harm disguised as health? buff.ly/2MyPSMF #Skincare #Pediatrics #TikTok

🎥 Did you know TikTok is reshaping conversations about #irritableboweldisease? 🌍 Patients are turning to social media to connect, learn, & find community. 🔗 Read more here: buff.ly/r5WJ3ck #IBDAwareness #Crohns #UlcerativeColitis #Healthcare

🧬 A new study from #ASCO25 explores neoadjuvant #pepinemab in #headandneckcancer treatment 🔬 Aims to prime #tumor immunity before surgical intervention 📈 Potentially enhancing patient outcomes through immune activation 🔗 Read more: buff.ly/ej6hM9Q

IBD ≠ pneumonia risk—unless other factors are at play. A new study shows comorbidities (12x) and steroid use (2x) are the real drivers of pneumonia in IBD—not the disease itself. buff.ly/TkwsIlY #IBD #InfectionRisk #Pneumonia

⚠️ New study links central obesity to higher psoriasis risk 📏 Waist circumference may be more telling than BMI 🧬 Highlights need for targeted screening & prevention 🔗 buff.ly/nPB2jku #Psoriasis #Obesity #Inflammation #Dermatology #ChronicDisease

🚨 @US_FDA has approved #dupilumab for #bullouspemphigoid 🎯 18.3% achieved sustained remission 🧪 Less steroid use, less itch, better outcomes 🔗 buff.ly/VtfRuzH #Dermatology #FDAapproval

🐶 Can dogs help prevent eczema in kids with genetic risk? 🧬 New research says early-life dog exposure may reduce eczema risk—even in those genetically predisposed. 📖 Dive into the findings: buff.ly/TAHNxJl #Eczema #Pediatrics #AllergyPrevention #Genetics

👶 New study links paternal psychological distress to delays in early child development 🧠 Impacts seen as early as 12 months 💡 Highlights the need for paternal mental health screening 🔗 buff.ly/QlZrIRX #ChildDevelopment #MentalHealth #Pediatrics #PublicHealth

🥼 Mediterranean vs. low-FODMAP: Which diet better supports IBS symptom control in clinical practice? 📊 New comparative data offers insights into efficacy and long-term feasibility. buff.ly/jLV1a6D #IBS #Gastroenterology #MedTwitter #NutritionScience #EvidenceBased

🧠 REM sleep apnea may be more harmful than we thought—it's linked to white matter changes and cognitive decline. 😴 A deeper look into how sleep phases impact brain health. 🔗 buff.ly/1pUiUSP #SleepHealth #BrainResearch #REM #SleepApnea #Cognition

💊 71% of patients with sleep disorders preferred solriamfetol over modafinils in a real-world study. 🔄 Those who switched back cited better results or fewer side effects with modafinils. 🔗 Read more: buff.ly/s8IF3HY #SleepHealth #Narcolepsy #Solriamfetol #Modafinil

🧬 A new study examines pembrolizumab plus lenvatinib in uterine carcinosarcoma 📊 Results were shared at #ASCO25, highlighting clinical benefit in select patients 🔗 buff.ly/My4e4f1 #UterineCancer #Immunotherapy #CancerResearch #ASCO25

🧬🔍 New insights into #uterine #leiomyosarcoma! A study presented at #ASCO25 analyzes the genetic profile of LMS using a national database. 📄 Read more: buff.ly/c5D5GES #UterineCancer #GenomicProfiling #CancerResearch #ASCO25

🔬 #ASCO25 📈 Concurrent chemoradiotherapy (CCRT) shows superior outcomes 🧪 CCRT outperforms radiotherapy and surgery in overall and progression-free survival 💡 Combining CCRT with other therapies offers comparable efficacy 🔗 Read more: buff.ly/Cra55Vv

🚨 New research presented at #ASCO25 out of @MSKCancerCenter: 🧬 #Papsmear #ctDNA allows for earlier identification of #endometrialcancer 🔗 Read more: buff.ly/VEiTufb #ctDNA #CancerDetection #EarlyDiagnosis #WomensHealth #MedicalInnovation #LiquidBiopsy

#ASCO25 🩺 📊 New data highlight clinical predictors of early #cutaneousmelanoma recurrence. 📈 Key variables may guide post-treatment surveillance and decision-making. 🔗 buff.ly/dznq8Ka #Melanoma #Oncology #CancerRecurrence #ClinicalResearch #SkinCancer #DermOnc

#ASCO25 🚀 🧬 New research reveals how #organoids provide key insight into #melanoma drug resistance. 🧪 Could this be a turning point in personalized cancer therapies? 🔗 buff.ly/vkOLnvQ #CancerResearch #Melanoma #Organoids #DrugResistance #Oncology

🚨 New eczema research is in! 🔍 Find out who benefits most from #lebrikizumab and when. 👉 Read more: buff.ly/HOxWrFg #Eczema #Dermatology #Lebrikizumab #HealthNews #SkinCare

🧬 Exciting news in dermatology! Upadacitinib shows promise for treating hidradenitis suppurativa. 📊 In a phase 2 trial, 38.3% achieved HiSCR50 at week 12 vs. 25% with placebo. 🔗 buff.ly/BEW2lJZ #HidradenitisSuppurativa #Upadacitinib #Dermatology #ClinicalTrials

🔍 #Obesity isn't just about choices—it's a chronic disease. 🧬 It’s time to shift the narrative and treat it with empathy, science, and support. 📖 Dive into this eye-opening read: buff.ly/VmVLdf5 #ObesityAwareness #ChronicDisease #HealthcareMatters #EndStigma